• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[两例遗传性蛋白C缺乏症致静脉血栓形成的病例分析]

[Analysis of two cases of hereditary protein C deficiency causing venous thrombosis].

作者信息

Wen M Z, Lu Y F, Liu M N, Qin L Y, Jin Y H, Wang M S, Yang L L

机构信息

Department of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou 325015, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2025 Mar 14;46(3):244-251. doi: 10.3760/cma.j.cn121090-20240628-00236.

DOI:10.3760/cma.j.cn121090-20240628-00236
PMID:40355354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12038477/
Abstract

To investigate the molecular pathogenic mechanism of venous thrombosis caused by heterozygous missense mutations in two protein C (PROC) genes through laboratory phenotype analysis, genetic mutation analysis, and in vitro expression experiments. Two probands presented with venous thromboembolism at the First Affiliated Hospital of Wenzhou Medical University. Clinical data and blood samples were collected from the probands and their family members to evaluate the plasma protein C (PC) activity (PC∶A), PC antigen (PC∶Ag) levels, and other relevant coagulation parameters. The anticoagulant capacity was assessed using the thrombin generation test (TGT). The mutation sites of the PROC gene were identified using direct DNA sequencing. Bioinformatics software was used to analyze the conservation and pathogenicity of the mutated gene. PyMOL software was used for the analysis of the protein three-dimensional models and interactions between mutated amino acids. Wild-type and two mutant expression vectors were constructed and HEK293T cells were transiently transfected. Total cellular RNA was extracted from positively transfected cells to investigate the transcriptional levels of the mutant PROC gene. Enzyme-linked immunosorbent assay, Western blot, and cellular immunofluorescence assays were used to investigate the translation levels of the mutant PROC protein. Probands 1 and 2 exhibited PC∶A levels of 35% and 40% and PC∶Ag levels of 44% and 39%, with increasing D-dimer levels to 4.42 mg/L and 0.83 mg/L, respectively. Meanwhile, other coagulation parameters revealed no significant abnormalities. TGT demonstrated impaired anticoagulant function in both proband witnesses and their familial PC carriers. Sequencing analysis revealed heterozygous missense mutations c. 833T>C (p. Leu278Pro) in proband 1 and c. 1330T>C (p. Trp444Arg) in proband 2 within exon 9 of the PROC gene. Conservation analysis revealed that Leu278 and Trp444 were highly conserved across homologous species. Pathogenicity analysis indicated that both p. Leu278Pro and p. Trp444Arg mutations are deleterious. Protein modeling analysis demonstrated that both mutations induce structural alterations in the protein. In vitro expression experiments revealed that compared with the wild-type, both p. Leu278Pro and p. Trp444Arg mutations showed no significant differences in the mRNA expression level of the PC protein. However, both mutations caused significantly lower PC∶Ag content and protein expression levels in the cell culture supernatant compared with the wild-type, whereas higher levels were observed in the cell culture lysate. This indicates the association of both mutations with the secretion function of the PC protein. The heterozygous missense mutations p. Leu278Pro and p. Trp444Arg in exon 9 of the PROC gene in both probands are associated with decreased PC levels.

摘要

通过实验室表型分析、基因突变分析和体外表达实验,研究两个蛋白C(PROC)基因杂合错义突变导致静脉血栓形成的分子致病机制。两名先证者在温州医科大学附属第一医院出现静脉血栓栓塞。收集先证者及其家庭成员的临床资料和血样,以评估血浆蛋白C(PC)活性(PC∶A)、PC抗原(PC∶Ag)水平及其他相关凝血参数。采用凝血酶生成试验(TGT)评估抗凝能力。使用直接DNA测序鉴定PROC基因的突变位点。利用生物信息学软件分析突变基因的保守性和致病性。使用PyMOL软件分析蛋白质三维模型以及突变氨基酸之间的相互作用。构建野生型和两个突变型表达载体,并瞬时转染HEK293T细胞。从阳性转染细胞中提取总细胞RNA,以研究突变PROC基因的转录水平。采用酶联免疫吸附测定、蛋白质印迹和细胞免疫荧光测定法研究突变PROC蛋白的翻译水平。先证者1和先证者2的PC∶A水平分别为35%和40%,PC∶Ag水平分别为44%和39%,D - 二聚体水平分别升高至4.42 mg/L和0.83 mg/L。同时,其他凝血参数未显示明显异常。TGT显示先证者及其家族性PC携带者的抗凝功能受损。测序分析显示,先证者1的PROC基因第9外显子存在杂合错义突变c. 833T>C(p. Leu278Pro),先证者2存在杂合错义突变c. 1,330T>C(p. Trp444Arg)。保守性分析显示,Leu278和Trp444在同源物种中高度保守。致病性分析表明,p. Leu278Pro和p. Trp444Arg突变均有害。蛋白质建模分析表明,这两个突变均导致蛋白质结构改变。体外表达实验显示,与野生型相比,p. Leu278Pro和p. Trp444Arg突变在PC蛋白的mRNA表达水平上无显著差异。然而,与野生型相比,这两个突变均导致细胞培养上清液中PC∶Ag含量和蛋白质表达水平显著降低,而在细胞培养裂解物中观察到较高水平。这表明这两个突变均与PC蛋白的分泌功能有关。两名先证者PROC基因第9外显子的杂合错义突变p. Leu278Pro和p. Trp444Arg与PC水平降低有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/f5485f92c229/cjh-46-03-244-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/95615655b5ce/cjh-46-03-244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/c5905f743f32/cjh-46-03-244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/52f427f7a848/cjh-46-03-244-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/b895b6faa9b9/cjh-46-03-244-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/13fbc31d3844/cjh-46-03-244-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/78ee0b271264/cjh-46-03-244-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/a17df0ed8ee0/cjh-46-03-244-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/69125bc1fa08/cjh-46-03-244-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/fabccc4477a4/cjh-46-03-244-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/5e53b5f5c8c1/cjh-46-03-244-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/f5485f92c229/cjh-46-03-244-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/95615655b5ce/cjh-46-03-244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/c5905f743f32/cjh-46-03-244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/52f427f7a848/cjh-46-03-244-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/b895b6faa9b9/cjh-46-03-244-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/13fbc31d3844/cjh-46-03-244-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/78ee0b271264/cjh-46-03-244-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/a17df0ed8ee0/cjh-46-03-244-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/69125bc1fa08/cjh-46-03-244-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/fabccc4477a4/cjh-46-03-244-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/5e53b5f5c8c1/cjh-46-03-244-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255d/12038477/f5485f92c229/cjh-46-03-244-g011.jpg

相似文献

1
[Analysis of two cases of hereditary protein C deficiency causing venous thrombosis].[两例遗传性蛋白C缺乏症致静脉血栓形成的病例分析]
Zhonghua Xue Ye Xue Za Zhi. 2025 Mar 14;46(3):244-251. doi: 10.3760/cma.j.cn121090-20240628-00236.
2
Molecular and clinical characterization of two independent Chinese families with protein C deficiency.两个中国独立蛋白C缺乏症家系的分子与临床特征
Ann Hematol. 2025 Jan;104(1):145-154. doi: 10.1007/s00277-024-06156-2. Epub 2024 Dec 26.
3
Analysis of four hereditary protein C deficiencies associated with vascular thromboembolism.分析与血管血栓栓塞相关的四种遗传性蛋白 C 缺乏症。
Ann Hematol. 2024 Jun;103(6):2145-2155. doi: 10.1007/s00277-024-05674-3. Epub 2024 Mar 4.
4
Compound heterozygous protein C deficiency in a family with venous thrombosis: Identification and in vitro study of p.Asp297His and p.Val420Leu mutations.一个患有静脉血栓形成家族中的复合杂合蛋白C缺乏症:p.Asp297His和p.Val420Leu突变的鉴定及体外研究
Gene. 2015 May 25;563(1):35-40. doi: 10.1016/j.gene.2015.03.002. Epub 2015 Mar 4.
5
Two heterozygous mutations associated with type I protein C deficiency in two Chinese independent families.两个中国独立家系中与I型蛋白C缺乏症相关的两个杂合突变。
Blood Coagul Fibrinolysis. 2021 Dec 1;32(8):596-602. doi: 10.1097/MBC.0000000000001065.
6
Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.对蛋白 C 缺乏症的遗传背景分析显示,在中国人群中与静脉血栓形成相关的一种反复出现的突变。
PLoS One. 2012;7(4):e35773. doi: 10.1371/journal.pone.0035773. Epub 2012 Apr 24.
7
[Clinical phenotype and gene mutation analysis of 12 patients with hereditary protein C deficiency in different families].[不同家系12例遗传性蛋白C缺乏症患者的临床表型及基因突变分析]
Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):35-40. doi: 10.3760/cma.j.issn.0253-2727.2022.01.008.
8
Homozygous protein C deficiency with late onset venous thrombosis: identification and in vitro expression study of a novel Pro275Ser mutation.纯合子蛋白 C 缺乏症伴迟发性静脉血栓形成:新型 Pro275Ser 突变的鉴定和体外表达研究。
Pathology. 2012 Jun;44(4):348-53. doi: 10.1097/PAT.0b013e328353a218.
9
[Molecular mechanisms of recurrent venous thrombosis in two pedigrees with type I antithrombin deficiency].[两个抗凝血酶I缺乏家系复发性静脉血栓形成的分子机制]
Zhonghua Xue Ye Xue Za Zhi. 2011 Dec;32(12):848-53.
10
[Analysis of phenotypes and genetic mutations in two pedigrees affected with hereditary protein C deficiency].[两个遗传性蛋白C缺乏症家系的表型与基因突变分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017 Feb 10;34(1):10-14. doi: 10.3760/cma.j.issn.1003-9406.2017.01.003.

本文引用的文献

1
[Clinical characteristics and gene mutation analysis of two families with hereditary protein C deficiency].[两个遗传性蛋白C缺乏症家系的临床特征及基因突变分析]
Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):952-955. doi: 10.3760/cma.j.issn.0253-2727.2023.11.013.
2
The Benefits and Imperative of Venous Thromboembolism Risk Screening for Hospitalized Patients: A Systematic Review.住院患者静脉血栓栓塞风险筛查的益处与必要性:一项系统评价
J Clin Med. 2023 Nov 9;12(22):7009. doi: 10.3390/jcm12227009.
3
Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy.
中性粒细胞胞外诱捕网介导深静脉血栓形成:从机制到治疗。
Front Immunol. 2023 Aug 23;14:1198952. doi: 10.3389/fimmu.2023.1198952. eCollection 2023.
4
Hereditary protein C deficiency with portal vein thrombosis in a Chinese male: A case report.一名中国男性患遗传性蛋白C缺乏症伴门静脉血栓形成:病例报告
Exp Ther Med. 2022 Nov 8;24(6):751. doi: 10.3892/etm.2022.11688. eCollection 2022 Dec.
5
Compound heterozygous protein C deficiency with pulmonary embolism caused by a novel PROC gene mutation: Case report and literature review.杂合子蛋白 C 缺乏症合并新型 PROC 基因突变致肺栓塞 1 例并文献复习
Medicine (Baltimore). 2022 Oct 21;101(42):e31221. doi: 10.1097/MD.0000000000031221.
6
Pathophysiology of deep vein thrombosis.深静脉血栓形成的病理生理学。
Clin Exp Med. 2023 Jul;23(3):645-654. doi: 10.1007/s10238-022-00829-w. Epub 2022 Apr 26.
7
[Clinical phenotype and gene mutation analysis of 12 patients with hereditary protein C deficiency in different families].[不同家系12例遗传性蛋白C缺乏症患者的临床表型及基因突变分析]
Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):35-40. doi: 10.3760/cma.j.issn.0253-2727.2022.01.008.
8
Two heterozygous mutations associated with type I protein C deficiency in two Chinese independent families.两个中国独立家系中与I型蛋白C缺乏症相关的两个杂合突变。
Blood Coagul Fibrinolysis. 2021 Dec 1;32(8):596-602. doi: 10.1097/MBC.0000000000001065.
9
Ophthalmic manifestations of congenital protein C deficiency: a case report and mini review.先天性蛋白C缺乏症的眼部表现:一例报告及简要综述。
BMC Ophthalmol. 2020 Jul 13;20(1):282. doi: 10.1186/s12886-020-01424-x.
10
Role of the activation peptide in the mechanism of protein C activation.激活肽在蛋白 C 激活机制中的作用。
Sci Rep. 2020 Jul 6;10(1):11079. doi: 10.1038/s41598-020-68078-z.